Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michaela Novakova

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Cellular and Molecular Life Sciences : CMLS|June 28, 2025
Circadian ontogenetic metabolomics atlas: an interactive resource with insights from rat plasma, tissues, and fecesLucie Rudl Kulhava, Pavel Houdek, Michaela Novakova, et al.
Clinical Pharmacology and Therapeutics|January 20, 2026
Untargeted Metabolomics Identifies N-Lactoyl-Amino Acids as Dose-Responsive Plasma Biomarkers of Metformin Adherence in Type 2 DiabetesTomas Cajka, Jiri Hricko, Lucie Rudl Kulhava, et al.
Haematologica|July 11, 2020
DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switchMichaela Novakova, Marketa Zaliova, Karel Fiser, et al.
Frontiers in Cellular and Infection Microbiology|January 27, 2023
Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapyZuzana Reiss, Filip Rob, Martin Kolar, et al.
Journal of Immunological Methods|March 14, 2018
Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemiaŁukasz Sędek, Prisca Theunissen, Elaine Sobral da Costa, et al.
Cells|November 27, 2021
Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF TherapyDagmar Schierova, Radka Roubalova, Martin Kolar, et al.
Plos One|December 30, 2022
Association between ustekinumab therapy and changes in specific anti-microbial response, serum biomarkers, and microbiota composition in patients with IBD: A pilot studyFilip Rob, Dagmar Schierova, Zuzana Stehlikova, et al.
Journal of Immunology Research|June 29, 2023
Serum TGF-<i>β</i>1 and CD14 Predicts Response to Anti-TNF-<i>α</i> Therapy in IBDStepan Coufal, Miloslav Kverka, Jakub Kreisinger, et al.
Blood Advances|November 23, 2021
Expert-independent classification of mature B-cell neoplasms using standardized flow cytometry: a multicentric studySebastian Böttcher, Robby Engelmann, Georgiana Grigore, et al.
American Journal of Hematology|January 4, 2022
TLR8/TLR7 dysregulation due to a novel TLR8 mutation causes severe autoimmune hemolytic anemia and autoinflammation in identical twinsMartina Fejtkova, Martina Sukova, Katerina Hlozkova, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cellular and Molecular Life Sciences : CMLS|June 28, 2025
Circadian ontogenetic metabolomics atlas: an interactive resource with insights from rat plasma, tissues, and fecesLucie Rudl Kulhava, Pavel Houdek, Michaela Novakova, et al.
Clinical Pharmacology and Therapeutics|January 20, 2026
Untargeted Metabolomics Identifies N-Lactoyl-Amino Acids as Dose-Responsive Plasma Biomarkers of Metformin Adherence in Type 2 DiabetesTomas Cajka, Jiri Hricko, Lucie Rudl Kulhava, et al.
Haematologica|July 11, 2020
DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switchMichaela Novakova, Marketa Zaliova, Karel Fiser, et al.
Frontiers in Cellular and Infection Microbiology|January 27, 2023
Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapyZuzana Reiss, Filip Rob, Martin Kolar, et al.
Journal of Immunological Methods|March 14, 2018
Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemiaŁukasz Sędek, Prisca Theunissen, Elaine Sobral da Costa, et al.
Cells|November 27, 2021
Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF TherapyDagmar Schierova, Radka Roubalova, Martin Kolar, et al.
Plos One|December 30, 2022
Association between ustekinumab therapy and changes in specific anti-microbial response, serum biomarkers, and microbiota composition in patients with IBD: A pilot studyFilip Rob, Dagmar Schierova, Zuzana Stehlikova, et al.
Journal of Immunology Research|June 29, 2023
Serum TGF-<i>β</i>1 and CD14 Predicts Response to Anti-TNF-<i>α</i> Therapy in IBDStepan Coufal, Miloslav Kverka, Jakub Kreisinger, et al.
Blood Advances|November 23, 2021
Expert-independent classification of mature B-cell neoplasms using standardized flow cytometry: a multicentric studySebastian Böttcher, Robby Engelmann, Georgiana Grigore, et al.
American Journal of Hematology|January 4, 2022
TLR8/TLR7 dysregulation due to a novel TLR8 mutation causes severe autoimmune hemolytic anemia and autoinflammation in identical twinsMartina Fejtkova, Martina Sukova, Katerina Hlozkova, et al.
Pageof 3